Definium Therapeutics, Inc.
DFTX- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- SEC CIK
- 0001813814
In the last 90 days, Definium Therapeutics, Inc. insiders filed 0 open-market purchases and 6 sales; 362 institutions reported holding it in 13F filings for Q2 2026, worth $5.35B in total; Duquesne Family Office is the only superinvestor holding it.
Q3 2022 vs. Q2 2022
How the institutions holding Definium Therapeutics, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 156 | 101 | −55 |
| SharesConverted for a 1-for-15 split | 1.52M | 5.89M | +4.37M (+286.8%) |
| Value | $15.1M | $20.5M | +$5.44M (+36.0%) |
New holders (18)
Institutions that held Definium Therapeutics, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Alyeska Investment Group, L.P. | 1,000,000 | $3.50M | 0.04% |
| CVI Holdings, LLC | 652,374 | $2.28M | 0.18% |
| Empery Asset Management, LP | 187,500 | $656.0K | 3.90% |
| Telemetry Investments, L.L.C. | 105,500 | $369.0K | 0.60% |
| Kestra Private Wealth Services, LLC | 50,472 | $177.0K | 0.01% |
| Virtu Financial LLC | 35,910 | $126.0K | 0.01% |
| Wolverine Trading, LLC | 29,939 | $103.0K | 0.00% |
| XTX Topco Ltd | 20,831 | $73.0K | 0.02% |
| LMR Partners LLP | 10,211 | $36.0K | 0.00% |
| Equitec Proprietary Markets, LLC | 4,400 | $15.0K | 0.01% |
| Almanack Investment Partners, LLC. | 894 | $3.00K | 0.00% |
| Emfo, LLC | 600 | $2.00K | 0.00% |
| FinTrust Capital Advisors, LLC | 33 | $0 | 0.00% |
| Bogart Wealth, LLC | 100 | $0 | 0.00% |
| Wipfli Financial Advisors LLC, | 6 | $0 | 0.00% |
| Heritage Wealth Management, LLC | 19 | $0 | 0.00% |
| Robbins Farley LLC | 28 | $0 | 0.00% |
| SJS Investment Consulting Inc. | 2 | $0 | 0.00% |
Sold out (73)
Institutions that held Definium Therapeutics, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.